Evan Myrianthopoulos

EVAN MYRIANTHOPOULOS is CFO of DOR BioPharma, Inc. Evan is also
currently the President and founder of CVL Advisors, LLC, a financial
consulting firm specializing in the biotechnology sector. Prior to
founding CVL Advisors, Mr. Myrianthopoulos was a co-founder of Discovery
Laboratories, Inc., a public specialty pharmaceutical company developing
respiratory therapies. While at Discovery, Mr. Myrianthopoulos held the
positions of Chief Financial Officer and Vice President of Finance where
he was responsible for raising approximately $55 million in four private
placements. He also negotiated and managed Discovery’s merger with Ansan
Pharmaceuticals and Acute Therapeutics. Prior to co-founding Discovery,
Mr. Myrianthopoulos was a Technology Associate at Paramount Capital
Investments, L.L.C., a New York City based biotechnology venture capital
and investment banking firm. Prior to joining Paramount Capital, Mr.
Myrianthopoulos was a managing partner of S + M Capital Management, a
hedge fund which specialized in syndicated stock offerings and also
engaging in arbitrage of municipal and mortgage bonds. Prior to that,
Mr. Myrianthopoulos held senior positions in the treasury department at
the National Australia Bank where he was employed as a spot and
derivatives currency trader. Mr. Myrianthopoulos holds a B.S. in
Economics and Psychology from Emory University.